166 related articles for article (PubMed ID: 24742042)
1. Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1.
Ding X; Zhang B; Pei Q; Pan J; Huang S; Yang Y; Zhu Z; Lv Y; Zou X
BMC Cancer; 2014 Apr; 14():271. PubMed ID: 24742042
[TBL] [Abstract][Full Text] [Related]
2. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
Panichakul T; Intachote P; Wongkajorsilp A; Sripa B; Sirisinha S
Anticancer Res; 2006; 26(1A):259-65. PubMed ID: 16475706
[TBL] [Abstract][Full Text] [Related]
3. Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma.
Clawson KA; Borja-Cacho D; Antonoff MB; Saluja AK; Vickers SM
J Surg Res; 2010 Oct; 163(2):244-9. PubMed ID: 20691980
[TBL] [Abstract][Full Text] [Related]
4. Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-alpha) and triptolide.
Panichakul T; Wanun T; Reutrakul V; Sirisinha S
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):167-73. PubMed ID: 12587840
[TBL] [Abstract][Full Text] [Related]
5. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
6. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
7. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma.
Zhao X; Wen F; Wang W; Lu Z; Guo Q
Nutr Cancer; 2019; 71(2):246-256. PubMed ID: 30633583
[TBL] [Abstract][Full Text] [Related]
8. Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway.
Kim MJ; Lee TH; Kim SH; Choi YJ; Heo J; Kim YH
Int J Oncol; 2010 Nov; 37(5):1177-85. PubMed ID: 20878065
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.
Alsaied OA; Sangwan V; Banerjee S; Krosch TC; Chugh R; Saluja A; Vickers SM; Jensen EH
Surgery; 2014 Aug; 156(2):270-9. PubMed ID: 24953273
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
12. Triptolide induces s phase arrest and apoptosis in gallbladder cancer cells.
Hu YP; Tan ZJ; Wu XS; Liu TY; Jiang L; Bao RF; Shu YJ; Li ML; Weng H; Ding Q; Tao F; Liu YB
Molecules; 2014 Feb; 19(2):2612-28. PubMed ID: 24566325
[TBL] [Abstract][Full Text] [Related]
13. CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263.
Huang T; Ding X; Xu G; Chen G; Cao Y; Peng C; Shen S; Lv Y; Wang L; Zou X
Cell Death Dis; 2019 Aug; 10(8):602. PubMed ID: 31399555
[TBL] [Abstract][Full Text] [Related]
14. Triptolide sensitizes liver cancer cell lines to chemotherapy in vitro and in vivo.
Li Y; Hu S
Panminerva Med; 2014 Sep; 56(3):211-20. PubMed ID: 24352031
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor effects of triptolide on osteosarcoma cells in vitro and in vivo: an experimental research].
Shi QW; Li SG; Li J; Ling CQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 May; 33(5):659-63. PubMed ID: 23905387
[TBL] [Abstract][Full Text] [Related]
16. Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo.
Antonoff MB; Chugh R; Borja-Cacho D; Dudeja V; Clawson KA; Skube SJ; Sorenson BS; Saltzman DA; Vickers SM; Saluja AK
Surgery; 2009 Aug; 146(2):282-90. PubMed ID: 19628086
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
Li CJ; Chu CY; Huang LH; Wang MH; Sheu LF; Yeh JI; Hsu HY
Cancer Lett; 2012 Jun; 319(2):203-213. PubMed ID: 22306340
[TBL] [Abstract][Full Text] [Related]
18. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.
Carter BZ; Mak DH; Schober WD; McQueen T; Harris D; Estrov Z; Evans RL; Andreeff M
Blood; 2006 Jul; 108(2):630-7. PubMed ID: 16556893
[TBL] [Abstract][Full Text] [Related]
19. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
20. miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death.
Chen Z; Sangwan V; Banerjee S; Mackenzie T; Dudeja V; Li X; Wang H; Vickers SM; Saluja AK
Mol Cancer; 2013 Sep; 12(1):105. PubMed ID: 24025188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
